| Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma C Mao, M Poimenidou, BT Craig Cancers 16 (16), 2865, 2024 | 2 | 2024 |
| Abstract PR009: Functional inhibition of natural killer cells enables surgery-induced accelerated neuroblastoma tumor growth in a mouse model C Mao, MB Dwinell, D McAllister, M Poimenidou, BT Craig Cancer Research 84 (17_Supplement), PR009-PR009, 2024 | | 2024 |
| IMPACT OF CRYOPRESERVATION ON BISPECIFIC ANTI-CD20/ANTI-CD19 CAR T-CELLS ENERGY METABOLISM AND ACTIVATION M Poimenidou, D McAllister, CT Nguyen, B Johnson, T Fenske, P Hematti, ... Cytotherapy 26 (6), S189-S190, 2024 | | 2024 |
| TRANSCRIPTIONAL PROFILING REVEALS CRYOPRESERVATION OF LV20. 19 CAR-T CELLS AFFECTS FUNCTIONALITY CT Nguyen, D McAllister, M Poimenidou, B Johnson, P Hematti, ... Cytotherapy 26 (6), S185-S186, 2024 | | 2024 |
| Metabolic modulation unleashes immune vigor in murine pancreas tumors M Poimenidou, J Le, C Darnell, M AbuEid, D McAllister, M Dwinell The Journal of Immunology 212 (1_Supplement), 0370_5807-0370_5807, 2024 | | 2024 |
| Mitochondria targeted metabolic inhibitors promote lymphocyte infiltration into murine pancreatic tumors M Poimenidou, M AbuEid, D Drouillard, D McAllister, MB Dwinell The Journal of Immunology 210 (1_Supplement), 172.20-172.20, 2023 | | 2023 |
| Abstract P129: Ketogenic diet (KD) and targeting Warburg effect: Apparent toxicity of KD combination with 2-deoxy-D-glucose R Zielinski, M Poimenidou, M Khuong, K Grela, R Cardenas-Zuniga, ... Molecular Cancer Therapeutics 20 (12_Supplement), P129-P129, 2021 | | 2021 |
| Abstract P218: Annamycin, a novel non-cardiotoxic anthracycline with high activity against sarcomas metastatic to lungs R Zielinski, K Grela, R Cardenas-Zuniga, S Skora, I Fokt, M Poimenidou, ... Molecular Cancer Therapeutics 20 (12_Supplement), P218-P218, 2021 | | 2021 |
| Abstract PO-066: High uptake, retention, and in vivo activity of L-Annamycin in pancreatic cancer models Y Kang, R Zielinski, RC Zuniga, R Venugopal, M Poimenidou, ... Cancer Research 81 (22_Supplement), PO-066-PO-066, 2021 | | 2021 |
| EXTH-78. WP1874, A HIGHLY POTENT UNIQUE DNA BINDING AGENT WITH ENHANCED CNS UPTAKE R Zielinski, R Cardenas-Zuniga, M Poimenidou, M Remiszewski, E Felix, ... Neuro-Oncology 23 (Suppl 6), vi181, 2021 | | 2021 |
